Phenome-wide analyses establish a specific association between aortic valve PALMD expression and calcific aortic valve stenosis.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
28 08 2020
Historique:
received: 06 03 2020
accepted: 04 08 2020
entrez: 30 8 2020
pubmed: 30 8 2020
medline: 17 6 2021
Statut: epublish

Résumé

Calcific aortic valve stenosis (CAVS) is a frequent heart disease with significant morbidity and mortality. Recent genomic studies have identified a locus near the gene PALMD (palmdelphin) strongly associated with CAVS. Here, we show that genetically-determined expression of PALMD in the aortic valve is inversely associated with CAVS, with a stronger effect in women, in a meta-analysis of two large cohorts totaling 2359 cases and 350,060 controls. We further demonstrate the specificity of this relationship by showing the absence of other significant association between the genetically-determined expression of PALMD in 9 tissues and 852 phenotypes. Using genome-wide association studies meta-analyses of cardiovascular traits, we identify a significant colocalized positive association between genetically-determined expression of PALMD in four non-cardiac tissues (brain anterior cingulate cortex, esophagus muscularis, tibial nerve and subcutaneous adipose tissue) and atrial fibrillation. The present work further establishes PALMD as a promising molecular target for CAVS.

Identifiants

pubmed: 32859967
doi: 10.1038/s42003-020-01210-x
pii: 10.1038/s42003-020-01210-x
pmc: PMC7455695
doi:

Substances chimiques

Membrane Proteins 0
PALMD protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

477

Subventions

Organisme : CIHR
ID : PJT - 162344
Pays : Canada

Références

Lindroos, M., Kupari, M., Heikkila, J. & Tilvis, R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J. Am. Coll. Cardiol. 21, 1220–1225 (1993).
doi: 10.1016/0735-1097(93)90249-Z
Nkomo, V. T. et al. Burden of valvular heart diseases: a population-based study. Lancet 368, 1005–1011 (2006).
doi: 10.1016/S0140-6736(06)69208-8
Otto, C. M. & Prendergast, B. Aortic-valve stenosis-from patients at risk to severe valve obstruction. N. Engl. J. Med. 371, 744–756 (2014).
doi: 10.1056/NEJMra1313875
Mathieu, P. & Boulanger, M. C. Basic mechanisms of calcific aortic valve disease. Can. J. Cardiol. 30, 982–993 (2014).
doi: 10.1016/j.cjca.2014.03.029
Huygens, S. A., Goossens, L. M. A., van Erkelens, J. A., Takkenberg, J. J. M. & Rutten-van Molken, M. How much does a heart valve implantation cost and what are the health care costs afterwards? Open Heart 5, e000672 (2018).
doi: 10.1136/openhrt-2017-000672
Mathieu, P., Boulanger, M. C. & Bouchareb, R. Molecular biology of calcific aortic valve disease: towards new pharmacological therapies. Expert Rev. Cardiovasc. Ther. 12, 851–862 (2014).
doi: 10.1586/14779072.2014.923756
Viney, N. J. et al. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. Lancet 388, 2239–2253 (2016).
doi: 10.1016/S0140-6736(16)31009-1
Helgadottir, A. et al. Genome-wide analysis yields new loci associating with aortic valve stenosis. Nat. Commun. 9, 987 (2018).
doi: 10.1038/s41467-018-03252-6
Theriault, S. et al. A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis. Nat. Commun. 9, 988 (2018).
doi: 10.1038/s41467-018-03260-6
Bosse, Y., Mathieu, P. & Theriault, S. PALMD as a novel target for calcific aortic valve stenosis. Curr. Opin. Cardiol. 34, 105–111 (2019).
doi: 10.1097/HCO.0000000000000605
Nie, Y. et al. Palmdelphin promotes myoblast differentiation and muscle regeneration. Sci. Rep. 7, 41608 (2017).
doi: 10.1038/srep41608
Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
doi: 10.1371/journal.pmed.1001779
Bush, W. S., Oetjens, M. T. & Crawford, D. C. Unravelling the human genome-phenome relationship using phenome-wide association studies. Nat. Rev. Genet. 17, 129–145 (2016).
doi: 10.1038/nrg.2015.36
Denny, J. C., Bastarache, L. & Roden, D. M. Phenome-wide association studies as a tool to advance precision medicine. Annu. Rev. Genomics Hum. Genet. 17, 353–373 (2016).
doi: 10.1146/annurev-genom-090314-024956
Rastegar-Mojarad, M., Ye, Z., Kolesar, J. M., Hebbring, S. J. & Lin, S. M. Opportunities for drug repositioning from phenome-wide association studies. Nat. Biotechnol. 33, 342–345 (2015).
doi: 10.1038/nbt.3183
Barbeira, A. N. et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat. Commun. 9, 1825 (2018).
doi: 10.1038/s41467-018-03621-1
Gamazon, E. R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091–1098 (2015).
doi: 10.1038/ng.3367
Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245–252 (2016).
doi: 10.1038/ng.3506
Dashzeveg, N., Taira, N., Lu, Z. G., Kimura, J. & Yoshida, K. Palmdelphin, a novel target of p53 with Ser46 phosphorylation, controls cell death in response to DNA damage. Cell Death Dis. 5, e1221 (2014).
doi: 10.1038/cddis.2014.176
Hekselman, I. & Yeger-Lotem, E. Mechanisms of tissue and cell-type specificity in heritable traits and diseases. Nat. Rev. Genet. 21, 137–150 (2020).
doi: 10.1038/s41576-019-0200-9
Thériault, S. et al. Genetic association analyses highlight IL6, ALPL, and NAV1 As 3 new susceptibility genes underlying calcific aortic valve stenosis. Circulation. Genom. Precis. Med. 12, e002617 (2019).
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020).
doi: 10.1038/s41586-020-2308-7
Simard, L. et al. Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis: is valvular fibrosis the explanation? Circulation Res. 120, 681–691 (2017).
doi: 10.1161/CIRCRESAHA.116.309306
Siu, S. C. & Silversides, C. K. Bicuspid aortic valve disease. J. Am. Coll. Cardiol. 55, 2789–2800 (2010).
doi: 10.1016/j.jacc.2009.12.068
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
doi: 10.1038/s41586-018-0579-z
Stegle, O., Parts, L., Durbin, R. & Winn, J. A Bayesian framework to account for complex non-genetic factors in gene expression levels greatly increases power in eQTL studies. PLoS Comput. Biol. 6, e1000770 (2010).
doi: 10.1371/journal.pcbi.1000770
Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).
doi: 10.1038/ng2088
Delaneau, O. et al. A complete tool set for molecular QTL discovery and analysis. Nat. Commun. 8, 15452 (2017).
doi: 10.1038/ncomms15452
Battle, A., Brown, C. D., Engelhardt, B. E. & Montgomery, S. B. Genetic effects on gene expression across human tissues. Nature 550, 204–213 (2017).
doi: 10.1038/nature24277
Liu, B., Gloudemans, M. J., Rao, A. S., Ingelsson, E. & Montgomery, S. B. Abundant associations with gene expression complicate GWAS follow-up. Nat. Genet. 51, 768–769 (2019).
doi: 10.1038/s41588-019-0404-0
Nielsen, J. B. et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat. Genet. 50, 1234–1239 (2018).
doi: 10.1038/s41588-018-0171-3
Malik, R. et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat. Genet. 50, 524–537 (2018).
doi: 10.1038/s41588-018-0058-3

Auteurs

Zhonglin Li (Z)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Quebec City, QC, G1V 0A6, Canada.

Nathalie Gaudreault (N)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Quebec City, QC, G1V 0A6, Canada.

Benoit J Arsenault (BJ)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Quebec City, QC, G1V 0A6, Canada.
Department of Medicine, Laval University, Quebec City, QC, G1V 0A6, Canada.

Patrick Mathieu (P)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Quebec City, QC, G1V 0A6, Canada.
Department of Surgery, Laval University, Quebec City, QC, G1V 0A6, Canada.

Yohan Bossé (Y)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Quebec City, QC, G1V 0A6, Canada.
Department of Molecular Medicine, Laval University, Quebec City, QC, G1V 0A6, Canada.

Sébastien Thériault (S)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Quebec City, QC, G1V 0A6, Canada. sebastien.theriault@criucpq.ulaval.ca.
Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University, Quebec City, QC, G1V 0A6, Canada. sebastien.theriault@criucpq.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH